Adjuvants of Potential Value in Multiple Myeloma Treatment
Despite the development of novel chemotherapy regimens which are prolonging life in many patients with multiple myeloma, long term prognosis remains poor owing to the onset of chemoresistance. However, a number of available drugs have the potential to render this cancer more sensitive to chemotherapeutic agents, as suggested by the research abstracts posted here.